NKT TCR recognition of CD1d-α-C-galactosylceramide

Journal of Immunology

Volumn 187, Issue 9, 2011, Pages 4705-4713

  Patel, Onisha ^a   Cameron, Garth ^b   Pellicci, Daniel G ^b   Liu, Zheng ^c   Byun, Hoe Sup ^c   Beddoe, Travis ^a   McCluskey, James ^b   Franck, Richard W ^d   Castaño, A Raúl ^e   Harrak, Youssef ^f   Llebaria, Amadeu ^f   Bittman, Robert ^c   Porcelli, Steven A ^g   Godfrey, Dale I ^b   Rossjohn, Jamie ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c CITY UNIVERSITY OF NEW YORK   (United States)

^d CITY UNIVERSITY OF NEW YORK   (United States)

^e UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^f INSTITUTE OF ADVANCED CHEMISTRY OF CATALONIA IQAC CSIC   (Spain)

^g ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; GAMMA INTERFERON; INTERLEUKIN 4; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CRYSTAL STRUCTURE; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; HYDROGEN BOND; IMMUNE RESPONSE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; SPLEEN CELL; TH1 CELL;

ANIMALS; ANTIGENS, CD1D; CARBOHYDRATE CONFORMATION; CELLS, CULTURED; CRYSTALLOGRAPHY, X-RAY; GALACTOSYLCERAMIDES; LIGANDS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; NATURAL KILLER T-CELLS; PEPTIDE FRAGMENTS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA;

EID: 80555126091     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100794     Document Type: Article

References (40)

1. Godfrey, D. I., H. R. MacDonald, M. Kronenberg, M. J. Smyth, and L. Van Kaer. 2004. NKT cells: what's in a name? Nat. Rev. Immunol. 4: 231-237.
2. Bendelac, A., P. B. Savage, and L. Teyton. 2007. The biology of NKT cells. Annu. Rev. Immunol. 25: 297-336. (Pubitemid 46697911)
3. Wingender, G., P. Rogers, G. Batzer, M. S. Lee, D. Bai, B. Pei, A. Khurana, M. Kronenberg, and A. A. Horner. 2011. Invariant NKT cells are required for airway inflammation induced by environmental antigens. J. Exp. Med. 208: 1151-1162.
4. Brigl, M., R. V. V. Tatituri, G. F. M. Watts, V. Bhowruth, E. A. Leadbetter, N. Barton, N. R. Cohen, F.-F. Hsu, G. S. Besra, and M. B. Brenner. 2011. Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection. J. Exp. Med. 208: 1163-1177.
5. Cerundolo, V., J. D. Silk, S. H. Masri, and M. Salio. 2009. Harnessing invariant NKT cells in vaccination strategies. Nat. Rev. Immunol. 9: 28-38.
6. Godfrey, D. I., and M. Kronenberg. 2004. Going both ways: immune regulation via CD1d-dependent NKT cells. J. Clin. Invest. 114: 1379-1388. (Pubitemid 40385565)
7. Godfrey, D. I., and J. Rossjohn. 2011. New ways to turn on NKT cells. J. Exp. Med. 208: 1121-1125.
8. Kawano, T., J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, K. Motoki, H. Ueno, R. Nakagawa, H. Sato, E. Kondo, et al. 1997. CD1d-restricted and TCRmediated activation of valpha14 NKT cells by glycosylceramides. Science 278: 1626-1629. (Pubitemid 27516282)
9. Cerundolo, V., P. Barral, and F. D. Batista. 2010. Synthetic iNKT cell-agonists as vaccine adjuvants - finding the balance. Curr. Opin. Immunol. 22: 417-424.
10. Kjer-Nielsen, L., N. A. Borg, D. G. Pellicci, T. Beddoe, L. Kostenko, C. S. Clements, N. A. Williamson, M. J. Smyth, G. S. Besra, H. H. Reid, et al. 2006. A structural basis for selection and cross-species reactivity of the semiinvariant NKT cell receptor in CD1d/glycolipid recognition. J. Exp. Med. 203: 661-673.
11. Pellicci, D. G., O. Patel, L. Kjer-Nielsen, S. S. Pang, L. C. Sullivan, K. Kyparissoudis, A. G. Brooks, H. H. Reid, S. Gras, I. S. Lucet, et al. 2009. Differential recognition of CD1d-alpha-galactosyl ceramide by the V beta 8.2 and V beta 7 semi-invariant NKT T cell receptors. Immunity 31: 47-59.
12. Borg, N. A., K. S. Wun, L. Kjer-Nielsen, M. C. Wilce, D. G. Pellicci, R. Koh, G. S. Besra, M. Bharadwaj, D. I. Godfrey, J. McCluskey, and J. Rossjohn. 2007. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor. Nature 448: 44-49. (Pubitemid 47037002)
13. Wun, K. S., G. Cameron, O. Patel, S. S. Pang, D. G. Pellicci, L. C. Sullivan, S. Keshipeddy, M. H. Young, A. P. Uldrich, M. S. Thakur, et al. 2011. A molecular basis for the exquisite CD1d-restricted antigen specificity and functional responses of natural killer T cells. Immunity 34: 327-339.
14. Aspeslagh, S., Y. Li, E. D. Yu, N. Pauwels, M. Trappeniers, E. Girardi, T. Decruy, K. Van Beneden, K. Venken, M. Drennan, et al. 2011. Galactosemodified iNKT cell agonists stabilized by an induced fit of CD1d prevent tumour metastasis. EMBO J. 30: 2294-2305.
15. Li, Y., E. Girardi, J. Wang, E. D. Yu, G. F. Painter, M. Kronenberg, and D. M. Zajonc. 2010. The Va14 invariant natural killer T cell TCR forces microbial glycolipids and CD1d into a conserved binding mode. J. Exp. Med. 207: 2383-2393.
16. Mallevaey, T., A. J. Clarke, J. P. Scott-Browne, M. H. Young, L. C. Roisman, D. G. Pellicci, O. Patel, J. P. Vivian, J. L. Matsuda, J. McCluskey, et al. 2011. A molecular basis for NKT cell recognition of CD1d-self-antigen. Immunity 34: 315-326.
17. Pellicci, D. G., A. J. Clarke, O. Patel, T. Mallevaey, T. Beddoe, J. Le Nours, A. P. Uldrich, J. McCluskey, G. S. Besra, S. A. Porcelli, L. Gapin, D. I. Godfrey, and J. Rossjohn. 2011. Recognition of β-linked self glycolipids mediated by natural killer T cell antigen receptors. Nat. Immunol. 12: 827-833.
18. Uldrich, A. P., O. Patel, G. Cameron, D. G. Pellicci, E. B. Day, L. C. Sullivan, K. Kyparissoudis, L. Kjer-Nielsen, J. P. Vivian, B. Cao, et al. 2011. A semiinvariant Vα10+ T cell antigen receptor defines a population of natural killer T cells with distinct glycolipid antigen-recognition properties. Nat. Immunol. 12: 616-623.
19. Godfrey, D. I., J. Rossjohn, and J. McCluskey. 2008. The fidelity, occasional promiscuity, and versatility of T cell receptor recognition. Immunity 28: 304-314. (Pubitemid 351343861)
20. Godfrey, D. I., D. G. Pellicci, O. Patel, L. Kjer-Nielsen, J. McCluskey, and J. Rossjohn. 2010. Antigen recognition by CD1d-restricted NKT T cell receptors. Semin. Immunol. 22: 61-67.
21. Scott-Browne, J. P., J. L. Matsuda, T. Mallevaey, J. White, N. A. Borg, J. McCluskey, J. Rossjohn, J. Kappler, P. Marrack, and L. Gapin. 2007. Germline-encoded recognition of diverse glycolipids by natural killer T cells. Nat. Immunol. 8: 1105-1113.
22. Florence, W. C., C. Xia, L. E. Gordy, W. Chen, Y. Zhang, J. Scott-Browne, Y. Kinjo, K. O. Yu, S. Keshipeddy, D. G. Pellicci, et al. 2009. Adaptability of the semi-invariant natural killer T-cell receptor towards structurally diverse CD1drestricted ligands. EMBO J. 28: 3579-3590.
23. Wun, K. S., N. A. Borg, L. Kjer-Nielsen, T. Beddoe, R. Koh, S. K. Richardson, M. Thakur, A. R. Howell, J. P. Scott-Browne, L. Gapin, et al. 2008. A minimal binding footprint on CD1d-glycolipid is a basis for selection of the unique human NKT TCR. J. Exp. Med. 205: 939-949. (Pubitemid 351549889)
24. Mallevaey, T., J. P. Scott-Browne, J. L. Matsuda, M. H. Young, D. G. Pellicci, O. Patel, M. Thakur, L. Kjer-Nielsen, S. K. Richardson, V. Cerundolo, et al. 2009. T cell receptor CDR2 beta and CDR3 beta loops collaborate functionally to shape the iNKT cell repertoire. Immunity 31: 60-71.
25. Matulis, G., J. P. Sanderson, N. M. Lissin, M. B. Asparuhova, G. R. Bommineni, D. Schuαmperli, R. R. Schmidt, P. M. Villiger, B. K. Jakobsen, and S. D. Gadola. 2010. Innate-like control of human iNKT cell autoreactivity via the hypervariable CDR3beta loop. PLoS Biol. 8: e1000402.
26. Venkataswamy, M. M., and S. A. Porcelli. 2010. Lipid and glycolipid antigens of CD1d-restricted natural killer T cells. Semin. Immunol. 22: 68-78.
27. Banchet-Cadeddu, A., E. Henon, M. Dauchez, J.-H. Renault, F. Monneaux, and A. Haudrechy. The stimulating adventure of KRN 7000. Org. Biomol. Chem. 9: 3080-3104.
28. Miyamoto, K., S. Miyake, and T. Yamamura. 2001. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 413: 531-534. (Pubitemid 32938752)
29. Yu, K. O., J. S. Im, A. Molano, Y. Dutronc, P. A. Illarionov, C. Forestier, N. Fujiwara, I. Arias, S. Miyake, T. Yamamura, et al. 2005. Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides. Proc. Natl. Acad. Sci. USA 102: 3383-3388. (Pubitemid 40328054)
30. Schmieg, J., G. Yang, R. W. Franck, and M. Tsuji. 2003. Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-Galactosylceramide. J. Exp. Med. 198: 1631-1641. (Pubitemid 37494156)
31. Lu, X., L. Song, L. S. Metelitsa, and R. Bittman. 2006. Synthesis and evaluation of an α-C-galactosylceramide analogue that induces Th1-biased responses in human natural killer T cells. ChemBioChem 7: 1750-1756. (Pubitemid 44748660)
32. Fujii, S.-i., K. Shimizu, H. Hemmi, M. Fukui, A. J. Bonito, G. Chen, R. W. Franck, M. Tsuji, and R. M. Steinman. 2006. Glycolipid alpha- Cgalactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice. Proc. Natl. Acad. Sci. USA 103: 11252-11257. (Pubitemid 44156505)
33. Teng, M. W., J. A. Westwood, P. K. Darcy, J. Sharkey, M. Tsuji, R. W. Franck, S. A. Porcelli, G. S. Besra, K. Takeda, H. Yagita, et al. 2007. Combined natural killer T-cell based immunotherapy eradicates established tumors in mice. Cancer Res. 67: 7495-7504. (Pubitemid 47206579)
34. Sullivan, B. A., N. A. Nagarajan, G. Wingender, J. Wang, I. Scott, M. Tsuji, R. W. Franck, S. A. Porcelli, D. M. Zajonc, and M. Kronenberg. 2010. Mechanisms for glycolipid antigen-driven cytokine polarization by Valpha14i NKT cells. J. Immunol. 184: 141-153.
35. Liu, Z., H.-S. Byun, and R. Bittman. 2010. Synthesis of immunostimulatory alpha-C-galactosylceramide glycolipids via Sonogashira coupling, asymmetric epoxidation, and trichloroacetimidate-mediated epoxide opening. Org. Lett. 12: 2974-2977.
36. Collaborative Computational Project, Number 4. 1994. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 50: 760-763.
37. Zwart, P. H., P. V. Afonine, R. W. Grosse-Kunstleve, L. W. Hung, T. R. Ioerger, A. J. McCoy, E. McKee, N. W. Moriarty, R. J. Read, J. C. Sacchettini, et al. 2008. Automated structure solution with the PHENIX suite. Methods Mol. Biol. 426: 419-435.
38. DeLano, W. L. 2002. The PyMOL molecular graphics system. Available at: http://www.pymol.org. Accessed: March-June 2011.
39. Harrak, Y., C. M. Barra, A. Delgado, A. R. Castaño, and A. Llebaria. 2011. Galacto-configured aminocyclitol phytoceramides are potent in vivo invariant natural killer T cell stimulators. J. Am. Chem. Soc. 133: 12079-12084.
40. Im, J. S., P. Arora, G. Bricard, A. Molano, M. M. Venkataswamy, I. Baine, E. S. Jerud, M. F. Goldberg, A. Baena, K. O. Yu, et al. 2009. Kinetics and cellular site of glycolipid loading control the outcome of natural killer T cell activation. Immunity 30: 888-898.